BSE filing, NSE: GKSL. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Kidney and Super Speciality Ltd: key numbers
- Share price
- ₹163.31
- Market cap
- ₹1,288 Cr
- Revenue (annual)
- ₹82.01 Cr
- Net profit (annual)
- ₹15.50 Cr
- P/E (TTM)
- 81.3×Sector 52.8×
- Promoter holding
- 71.45%+0.00% QoQ
- FII holding
- 6.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Kidney and Super Speciality Ltd
All →Gujarat Kidney and Super Speciality Board Meeting Date
Gujarat Kidney will hold a board meeting on 04 Nov 2026 to consider unaudited quarterly results. The trading window closes from 01 Oct 2026.
Gujarat Kidney and Super Speciality Other Announcement
This is a routine quarterly shareholding pattern disclosure for the period ended September 30, 2026, filed under SEBI Regulation 31.
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited held its 7th Annual General Meeting on September 28, 2026. Shareholders approved financial statements, director appointments, and various regulatory borrowing and investment limits.
Gujarat Kidney and Super Speciality Annual Report
Gujarat Kidney and Super Speciality Limited issued a corrigendum to its FY 2025-26 Annual Report. The update includes missing Secretarial Audit observations and management responses.
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited has issued a notice for its 7th Annual General Meeting scheduled for September 28, 2026. The meeting will address financial statements, director appointments, and related party transactions.
- Value
- ₹1.78 Cr
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited filed a revised Annual Report for FY 2025-26. The document also includes the notice for its 7th Annual General Meeting.
Other management change announcements
All →Premier Explosives Management Change
Premier Explosives disclosed that Lt. Gen. Peruvemba Ramachandran Kumar ceases as Independent Director on completing his second five-year term, effective close of business on 1 November 2026. The company placed on record its appreciation for his contributions.
Axis Bank Management Change
Axis Bank disclosed that Independent Director Girish Paranjpe ceased to be a director on completion of his tenure, effective close of business on 1 November 2026. No monetary value is involved in this change.
KSB Management Change
KSB Limited announced Uday Joshi's designation as General Manager – Project Contract Management from November 1, 2026. It also disclosed the superannuation cessation of Mukesh Pattewar as Head – Project and Contract Management, effective December 31, 2026.
Oil And Natural Gas Corporation Management Change
ONGC disclosed that Executive Director Sanjay Kumar Singh retires on superannuation effective 1 November 2026. Deepali Masirkar joins as Executive Director on deputation from 28 October 2026.
Kingfa Science & Technology (India) Management Change
Kingfa disclosed that Nilima Ramrao Shinde ceased as Non-Executive Independent Director on tenure completion, effective 31 October 2026. No monetary value is involved.
Ashika Global Securities Management Change
Ashika Global Securities disclosed the re-appointment of Amit Jain as Whole-Time Director of unlisted material subsidiary Ashika Stock Services for three years from 1 November 2026. The filing reports a senior management reappointment with no monetary value.
- Execution
- 3 years, 01 November 2026 to 31 October 2029